脊髓刺激市場規模、佔有率和成長分析（按適應症、產品、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，脊髓刺激 (SCS) 市場規模將達到 35 億美元，到 2025 年將成長至 37.6 億美元，到 2033 年將成長至 67.5 億美元，在預測期（2026-2033 年）內複合年成長率為 7.58%。

脊髓刺激（SCS）是一種神經調控設備，其透過傳遞電訊號阻斷疼痛感知來緩解慢性疼痛的能力正日益受到關注。這種治療方法在治療脊椎相關疾病引起的疼痛以及背部、手臂和腿部的不適方面尤其有效，尤其適用於對傳統治療方法無效的患者。推動市場成長的關鍵因素包括技術進步、SCS手術相關法規的製定以及微創技術的日益普及。由於久坐不動的生活方式導致慢性疼痛盛行率不斷上升，SCS市場正在經歷顯著擴張，為其在醫療保健領域的持續成長和進一步發展奠定了基礎。

脊髓刺激市場促進因素

隨著製造商加強研發力度，致力於開發更緊湊的脊髓刺激設備，脊髓刺激設備市場正在蓬勃發展。例如，Stimwave LCC公司生產的Freedom SCS系統比目前市面上的植入式脈衝產生器（IPG）小約5%。這種小型化趨勢不僅提高了患者的舒適度，也促進了脈衝發生技術的進步。這些創新在推動市場需求方面發揮關鍵作用，為改善治療效果提供了契機，並為尋求緩解慢性疼痛的患者創造了更有利的環境。

限制脊髓刺激市場發展的因素

脊髓刺激市場面臨植入費用高昂的嚴峻挑戰，費用從21,000美元到58,000美元不等。這些費用因患者的醫療保險計劃以及是否需要自付費用而有所不同。此外，持續的維護費用，例如硬體費用、醫療專業人員費用、脈衝發生器更換費用和住院費用，也加重了患者的經濟負擔。初始費用和持續維護費用的疊加顯著限制了市場成長，總成本可能成為許多潛在患者的阻礙因素。

脊髓刺激市場趨勢

脊髓刺激市場正經歷顯著成長，這主要得益於各國政府加強減少鴉片類藥物成癮。隨著全球醫療系統轉向替代性疼痛管理方案，脊髓刺激設備作為一種有效的非鴉片類療法正日益受到關注。眾多公司提交的創新解決方案申請正在尋求快速核准，以期取代鴉片類藥物用於疼痛管理，這充分證明了此類設備日益成長的市場接受度。此外，Medtronic、雅培和波士頓醫療設備，以滿足市場對更安全、無成癮性鎮痛方案日益成長的需求，進一步推動了這一市場轉變。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球脊髓刺激市場規模（按適應症和複合年成長率分類）（2026-2033 年）

• 背部手術失敗綜合症
• 複雜性局部疼痛症候群
• 椎間盤退化性疾病
• 其他

全球脊髓刺激市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 可充電裝置
• 不可充電設備

全球脊髓刺激市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心
• 其他

全球脊髓刺激市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Nevro Corp.（USA）
• Stimwave Technologies, Inc.（USA）
• Saluda Medical Pty Ltd.（Australia）
• Synapse Biomedical Inc.（USA）
• Cirtec Medical（USA）
• Nalu Medical, Inc.（USA）
• Beijing PINS Medical Co., Ltd.（China）
• Gimer Medical（China）
• BIOTRONIK SE & Co. KG（Germany）
• St. Jude Medical, Inc.（acquired by Abbott）（USA）
• NeuroSigma, Inc.（USA）
• Greatbatch, Inc.（USA）
• Curonix LLC（USA）
• Teliatry, Inc.（USA）
• Spinal Modulation（USA）
• NevroSpin（USA）
• Axonics Modulation Technologies, Inc.（USA）

結論與建議

Spinal Cord Stimulation Market size was valued at USD 3.5 Billion in 2024 and is poised to grow from USD 3.76 Billion in 2025 to USD 6.75 Billion by 2033, growing at a CAGR of 7.58% during the forecast period (2026-2033).

The demand for spinal cord stimulation (SCS), a neuromodulation device designed to alleviate chronic pain by emitting electrical signals to block pain perception, is on the rise. This therapy is particularly effective for managing pain associated with spinal issues, as well as discomfort in the back, arms, and legs, especially in patients unresponsive to traditional treatments. Key factors driving market growth include advancements in technology, the establishment of regulations governing SCS procedures, and the increasing acceptance of minimally invasive techniques. As sedentary lifestyles contribute to a higher prevalence of chronic pain, the SCS market is experiencing significant expansion, positioning it for continued growth and additional opportunities in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Spinal Cord Stimulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Spinal Cord Stimulation Market Segments Analysis

Global Spinal Cord Stimulation Market is segmented by indication, product, end user and region. Based on indication, the market is segmented into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease and others. Based on product, the market is segmented into rechargeable devices and non-rechargeable devices. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Spinal Cord Stimulation Market

The spinal cord stimulation market is experiencing growth as manufacturers ramp up their research initiatives to develop more compact spinal cord stimulators. For example, the Freedom SCS system produced by Stimwave LCC demonstrates a reduction in size, being approximately 5% smaller than current Implantable Pulse Generators (IPG) available. This trend towards smaller devices not only enhances patient comfort but also facilitates advancements in impulse generation technology. Such innovations play a significant role in driving demand within the market, presenting opportunities for improved therapy effectiveness and fostering a more favorable environment for patients seeking relief from chronic pain.

Restraints in the Spinal Cord Stimulation Market

The spinal cord stimulation market faces significant challenges due to the high costs associated with implantations, which can range from US$ 21,000 to US$ 58,000. These expenses vary based on the type of health insurance coverage the patient possesses or if they are paying out-of-pocket. Furthermore, ongoing maintenance costs, including hardware expenses, healthcare professionals' fees, pulse generator replacements, and hospitalization charges, add to the financial burden. This combination of initial and recurring costs presents a major restraint on market growth, as many potential patients may find the overall expenditure prohibitive.

Market Trends of the Spinal Cord Stimulation Market

The Spinal Cord Stimulation market is witnessing a significant upward trend driven by heightened government initiatives aimed at reducing opioid dependence. As healthcare systems globally pivot towards alternative pain management solutions, spinal cord stimulation devices are gaining traction as effective non-opioid therapies. The growing acceptance of these devices is evidenced by numerous submissions from companies seeking expedited approvals for innovative solutions to replace opioids in pain management. This market shift is further supported by established medical device companies, including Medtronic, Abbott, and Boston Scientific, which are actively engaging in research and development to capitalize on the increasing demand for safer, non-addictive pain relief options.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Spinal Cord Stimulation Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disc Disease
• Others

Global Spinal Cord Stimulation Market Size by Product & CAGR (2026-2033)

• Market Overview
• Rechargeable Devices
• Non-Rechargeable Devices

Global Spinal Cord Stimulation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Spinal Cord Stimulation Market Size & CAGR (2026-2033)

• North America (Indication, Product, End User)
  • US
  • Canada
• Europe (Indication, Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Indication, Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Indication, Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Indication, Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cirtec Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nalu Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gimer Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (acquired by Abbott) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greatbatch, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curonix LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teliatry, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spinal Modulation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NevroSpin (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics Modulation Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations